|Videos|November 20, 2016

Antibiotic Stewardship Programs in Hospital & Outpatient Settings

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, discusses antibiotic stewardship programs in both the hospital and outpatient settings.

Lauri A. Hicks, DO, captain, US Public Health Service, director, Office of Antibiotic Stewardship, medical director, Get Smart: Know When Antibiotics Work, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, discusses antibiotic stewardship programs in both the hospital and outpatient settings.

Interview Transcript (slightly modified for readability)

“Programs in hospitals are going to look quite a bit different than your antibiotic stewardship activities in the outpatient setting. So, I’ll start with hospitals; in hospitals, typically, your antibiotic stewardship team is comprised of a physician, a pharmacist, and ideally, multiple members of the healthcare team throughout the hospital. That means, we would really like to have nursing representation [and] representation from the critical care community within that hospital. We also believe that having a good connection and good relationships with the microbiology laboratory and the laboratory folks makes it more feasible to do stewardship. So, without a doubt, it requires the engagement of a number of different types of people throughout that system.

What I want to reinforce is that we view every single provider in the hospital as an antibiotic steward, whether it’s a hospitalist admitting the patient to the hospital to treat a patient with community-acquired pneumonia, the nurse who is administering the drug at the bedside, the medical student who is coming in and checking in on that patient, or their attending who’s also coming in and actually supervising that care. At every step of the way we are hoping and really trying to instill the concept that each and every healthcare provider can play a role in stewardship.

That is also the same for the outpatient space. So, whether we’re talking about a doctor in an outpatient clinic who runs a general practice clinic, or we’re talking about a nurse practitioner in a retail clinic, or a physician assistant working in an emergency room; all of these folks are critical for improving how antibiotics are used. In an outpatient setting, because there is not the same kind of infrastructure as there is in a hospital setting, we are looking toward individual clinicians to really take on this [role of stewardship] and make a commitment to practicing high quality prescribing. We’re also asking for facilities and health systems with clinics to make sure that they have principles and activities in place that facilitate appropriate antibiotic prescribing.”


Related to this article

This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
Treatment of Latent Tuberculosis in a Trice
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.